Lv2
178 积分 2025-01-21 加入
Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement
1个月前
已完结
High Efficacy and Tolerability of Daratumumab-Based Regimens in First-Line Treatment of Patients with Immunoglobulin Light Chain Amyloidosis: A Real-World Evidence Analysis
2个月前
已关闭
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab‐Treated Patients
3个月前
已完结
Amyloidosis and the Liver
3个月前
已关闭
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria
3个月前
已完结
Review article: gastrointestinal amyloidosis – clinical features, diagnosis and therapy
3个月前
已完结
Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges
4个月前
已完结
Diagnosis and Treatment of AL Amyloidosis
4个月前
已完结
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis
4个月前
已完结
Hepatic Response Dynamics in Newly Diagnosed Patients with Light-chain Amyloidosis: A Retrospective Cohort Study
4个月前
已完结
皖公网安备34019202002308
